newsfilter
← Latest News
GlobeNewswire·

Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec™1%

TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE:MVMD) (OTCQX:MVMDF) (FRA: 20MP) is pleased to announce the successful completion of its pre-clinical pharmacokinetic study - IM032 - in male beag